We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
271 hedge funds and large institutions have $1.47B invested in Amphastar Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 89 increasing their positions, 98 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
21% more call options, than puts
Call options by funds: $3.17M | Put options by funds: $2.61M
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.92% less ownership
Funds ownership: 70.69% → 69.78% (-0.92%)
9% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 98
2% less funds holding
Funds holding: 277 → 271 (-6)
11% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 53
30% less capital invested
Capital invested by funds: $2.09B → $1.47B (-$622M)
Holders
271
Holders Change
-6
Holders Change %
-2.17%
% of All Funds
3.9%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
47
Increased
89
Reduced
98
Closed
53
Calls
$3.17M
Puts
$2.61M
Net Calls
+$553K
Net Calls Change
-$610K
Top Buyers
Top Sellers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$61.8M |
| 2 |
Morgan Stanley
New York
|
-$30.1M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$8.02M |
| 4 |
BHWA
Beacon Harbor Wealth Advisors
Virginia Beach,
Virginia
|
-$6.38M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
-$4.79M |
